Become a Member

written by reader Cabot’s 5 Top Stocks to buy in 2016

By hearring, March 29, 2016

Any insight on the the stocks Cabot’s touting.
Ligand Pharmaceuticals (LGND)
Solar Edge (SEDG)
Universal Display

Thank you…Karen

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

5 Comments
Inline Feedbacks
View all comments
SoGiAm
March 30, 2016 10:50 am

$LGND-Karen, this is probably the best and most recent article by Travis on Ligand Pharmaceuticals: http://www.stockgumshoe.com/2016/01/irregulars-annual-review/

👍 11604
SoGiAm
March 30, 2016 10:56 am

$LGND also covered in this February article: http://www.stockgumshoe.com/2016/02/february-idea-of-the-month/ Best2You-Ben

Add a Topic
3413
👍 11604
Travis Johnson, Stock Gumshoe
March 30, 2016 11:40 am

I haven’t looked at Universal Display lately, or Solar Edge at all, but do, as sogiam notes, own Ligand and find it an appealing but fairly high risk holding. Not as risky as junior biotechs awaiting trial results, but riskier than the “royalties” idea might convey because they are extremely reliant on two royalties (Kyprolis and Promacta) for the lion’s share of income. There is potential for high reward as well, of course, and that depends on some of their other top half-dozen drugs in development getting approved and selling well enough to generate substantial royalties… and their cost base is very low, since they don’t do much of the science or development work.

Add a Topic
996
👍 21771

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
14
0
Would love your thoughts, please comment.x
()
x